疟疾疫苗无法诱导其序列内的保护性表位的抗体
Y Charoenvit1, W E Collins, T R Jones
1Infectious Diseases Department, Naval Medical Research Institute, Bethesda, MD 20889.
概括
开发有效的Plasmodium vivax疟疾亚单元疫苗需要针对特定的保护性表位. 用Plasmodium vivax circumsporozoite蛋白重复疫苗接种并没有给予保护,这凸显了微调免疫反应的必要性.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 寄生虫学的寄生虫学
背景情况:
- 活型疟原体 (Plasmodium vivax circumsporozoite,简称CS) 蛋白质是疟疾疫苗的一个关键标.
- 以前的疫苗策略集中在CS蛋白内重复的表位上.
研究的目的:
- 为了评估基于P. vivax CS蛋白重复的复合子单位疫苗的疗效.
- 调查特异性表位识别在对P.vivax疟疾的保护性免疫力中的作用.
主要方法:
- 赛米里被免疫的重组蛋白含有20个副本的P. vivax CS蛋白重复.
- 子被挑战使用P. vivax sporozoites以评估疫苗的疗效.
- 单克隆抗体NVS3,保护性对脊髓菌挑战,被用于表位图映射.
主要成果:
- 用CS蛋白重复免疫诱导高抗体标位,但未能预防P. vivax挑战.
- 接受保护性单克隆抗体NVS3的子显示出对虫诱导的疟疾有显著的保护.
- 皮层映射显示,NVS3在CS蛋白重复中识别了一种特定的四氨基酸序列 (AGDR),而这种序列并不是疫苗诱导的抗体的目标.
结论:
- 针对整个CS蛋白重复的抗体不足以保护P. vivax疟疾.
- 免疫反应的精细特异性,特别是对AGDR表位的识别,对于有效的亚单元疫苗设计至关重要.
- 未来的P.vivax疫苗开发应该集中在引起针对AGDR.等特定保护性表位的抗体上.
相关概念视频
Vaccinations
Overview
Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...


